| ADT | androgen deprivation therapy |
| AR | androgen receptor |
| EBRT | external beam radiation therapy |
| GM-CSF | granulocyte-macrophage colony stimulating factor |
| GVAX | cancer vaccine consisting of whole tumor cells that secrete GM-CSF |
| IDO | indoleamine 2,3 dioxygenase |
| mCRPC | metastatic castration-resistant prostate cancer |
| MDSC | myeloid-derived suppressor cells |
| MFS | metastasis-free survival |
| NaF | sodium fluoride |
| PAP | prostatic acid phosphatase |
| PROSTVAC | prostate cancer vaccine consisting of vaccinia encoding PSA as a primary immunization followed by fowlpox encoding PSA booster immunizations |
| PSA | prostate-specific antigen |
| PSMA | prostate-specific membrane antigen |
| Sip-T | sipuleucel-T, an FDA-approved autologous cellular vaccine for the treatment of prostate cancer |
| TRAMP | transgenic adenocarcinoma of the mouse prostate mouse model |
| Treg | regulatory T cells |